News

Offers more than 120 hours of temperature-controlled pharma product protection

ACC supports both clinical and commercial viral vector production

Expansion project addresses assay development demands

Offers over 100,000 square feet of pharma temperature-controlled storage

Organization’s PAI portfolio boosts drug R&D, process development for pharma manufacturers

Healthcare marketing agency acquisition augments company’s commercialization portfolio

WEF honor is for demonstration of leadership in adopting Industry 4.0 tech

Project is centered around drug substance manufacturing

Expected to improve patient centricity, simplify clinical development process through commercialization

Agreement featuring UK pharma services consultancy intends to grow PharmaLex's pan-European market access presence

P4 is partially operational in under two years

Partnership looks to provide supply chain support for products in this sector, ranging from early clinical phase to commercial scale

Powered by tech company’s platform that strives to accelerate clinical development, commercialization of new therapies

In an abrupt transition, Dr. McMurray-Heath is replaced by an interim CEO

Company's UDF warehousing now allows for storage as low as -80°C

Partnership uses a digital approach featuring conversational AI and remote patient monitoring to help speed up enrollment

Biopharma company's 100,000 square-foot California center will house its blood cancer treatments

HCP-driven partnership calls for greater engagement across the life science sector

Designation is powered by CDMO’s sustainability focus

Distributor is able to reach more patients as a result  

The latest people news happenings over the past month

Microbial production site’s manufacturing capacity to increase by 70% upon completion

Digital therapy will help support mental health of cancer patients

New facility will focus on company’s temperature-controlled pallet shipper rental program

CDMO boosts capabilities at Cambridge location

Include frost protection, air flow to protect pharmaceuticals

Will feature drug discovery, gene and RNA therapy technology

Decision due to European Commission decreasing its order